@article{11174b07595a4f18abcdb78973f2f3f9,
title = "Erratum: Ofatumumab, a novel CD20 monoclonal antibody, is active in patients with fludarabine- and alemtuzumab-refractory or bulky fludarabine-refractory chronic lymphocytic leukemia irrespective of prior rituximab (Clinical lymphoma \& Myeloma (2009) 9: 6 (E36) DOI: 10.3816/CLM.2009.n.098)",
author = "William Wierda and Thomas Kipps and Ji{\v r}{\'i} Mayer and Stephan Stilgenbauer and Williams, \{Cathy D.\} and Andrzej Hellmann and Tadeusz Robak and Furman, \{Richard R.\} and Peter Hillmen and Marek Trneny and Dyer, \{Martin J.S.\} and Swami Padmanabhan and Magdalena Piotrowska and Tomas Kozak and Geoffrey Chan and Randy Davis and Nedjad Losic and Joris Wilms and Charlotte Russell and Anders {\"O}sterborg",
year = "2010",
month = apr,
doi = "10.3816/CLML.2010.n.024",
language = "English (US)",
volume = "10",
pages = "157",
journal = "Clinical Lymphoma, Myeloma and Leukemia",
issn = "2152-2650",
publisher = "Elsevier",
number = "2",
}